One-Shot treatment tested to reset immune system in severe autoimmune diseases
NCT ID NCT07339540
Summary
This early-stage study is testing a new one-time treatment called V001-BCMA for people with severe autoimmune diseases that have not responded to standard therapies. The treatment uses a patient's own modified immune cells (CAR-T cells) to target and remove harmful B cells that drive the disease. The main goal is to see if this single infusion is safe and can help control diseases like lupus, scleroderma, and others in 45 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OR REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.